Creative Medical Gets IRB Approval For StemSpine Trial Using AlloStem Cell Therapy

RTTNews | 689 일 전
Creative Medical Gets IRB Approval For StemSpine Trial Using AlloStem Cell Therapy

(RTTNews) - Biotechnology company Creative Medical Technology Holdings, Inc. (CELZ) announced Tuesday that it has received Institutional Review Board (IRB) approval to proceed with its clinical trial for the treatment of chronic lower back pain with its StemSpine procedure using AlloStem (CELZ-201-DDT) cell therapy.

The receipt of IRB approval is a necessary step that will allow Creative Medical Technology to move forward with recruitment of its recently FDA approved Phase 1 /2 randomized, double blind, placebo controlled clinical trial to evaluate the safety, efficacy, and tolerability of CELZ-201-DDT.

The study will enroll 30 individuals suffering from chronic lower back pain caused by Degenerative Disc Disease.

FDA-regulated IRB's approval is a critical and necessary prerequisite to commencing human clinical trials and serves an important role in the protection of the rights and welfare of human research subjects.

CELZ-201-DDT is a patented procedure that utilizes an "off the shelf, ready-to-use" universal and proprietary allogenic (donor) cell line developed by the Company and trademarked as AlloStem.

read more
Asian Shares Mixed Ahead Of US PCE Inflation Data

Asian Shares Mixed Ahead Of US PCE Inflation Data

Asian stocks ended mixed on Friday as caution prevailed ahead of a key U.S. inflation report due later in the day that might show core personal consumption expenditures prices rose 2.9 percent in July, the fastest pace in five months.
RTTNews | 15 분 전
European Shares Seen Mostly Lower Before US Inflation Data

European Shares Seen Mostly Lower Before US Inflation Data

European stocks may open broadly lower on Friday as the prospect of a peace agreement between Russia and Ukraine waned and focus shifted to a key U.S. inflation reading due later in the day that could provide additional clues on the Federal Reserve's rate outlook.
RTTNews | 3 시간 13 분 전
Australian Market Swings To Modest Gains In Mid-market

Australian Market Swings To Modest Gains In Mid-market

The Australian stock market is swinging to modest gains in mid-market moves on Friday after opening in the red, extending the gains in the previous two sessions, following the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 9,000 mark, with gains in energy and technology stocks partially offset by weakness in mining and financial stocks.
RTTNews | 5 시간 17 분 전
Asian Markets Mixed Amid Caution Trades

Asian Markets Mixed Amid Caution Trades

Asian stock markets are mixed on Friday, following the broadly positive cues from Wall Street overnight, ahead of the release of key U.S. inflation data later in the day that could impact the outlook for interest rates. Traders also digested highly anticipated earnings news from Nvidia, with the AI darling and market leader reporting second-quarter results that largely exceeded expectations.
RTTNews | 5 시간 47 분 전